These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

305 related items for PubMed ID: 11181499

  • 1. Elevated alpha-1-acid glycoprotein reduces the volume of distribution and systemic clearance of saquinavir.
    Holladay JW, Dewey MJ, Michniak BB, Wiltshire H, Halberg DL, Weigl P, Liang Z, Halifax K, Lindup WE, Back DJ.
    Drug Metab Dispos; 2001 Mar; 29(3):299-303. PubMed ID: 11181499
    [Abstract] [Full Text] [Related]

  • 2. The disposition of saquinavir in normal and P-glycoprotein deficient mice, rats, and in cultured cells.
    Washington CB, Wiltshire HR, Man M, Moy T, Harris SR, Worth E, Weigl P, Liang Z, Hall D, Marriott L, Blaschke TF.
    Drug Metab Dispos; 2000 Sep; 28(9):1058-62. PubMed ID: 10950849
    [Abstract] [Full Text] [Related]

  • 3. Binding characteristics of KNI-272 to plasma proteins, a new potent tripeptide HIV protease inhibitor.
    Kiriyama A, Nishiura T, Ishino M, Yamamoto Y, Ogita I, Kiso Y, Takada K.
    Biopharm Drug Dispos; 1996 Dec; 17(9):739-51. PubMed ID: 8968527
    [Abstract] [Full Text] [Related]

  • 4. Pharmacokinetic characterization of a human immunodeficiency virus protease inhibitor, saquinavir, during ethanol intake in rats.
    Shibata N, Kageyama M, Kishida T, Kimura K, Yoshikawa Y, Kuwahara T, Toh J, Shirasaka T, Takada K.
    Biopharm Drug Dispos; 2003 Nov; 24(8):335-44. PubMed ID: 14595702
    [Abstract] [Full Text] [Related]

  • 5. Characterization of nelfinavir binding to plasma proteins and the lack of drug displacement interactions.
    Motoya T, Thevanayagam LN, Blaschke TF, Au S, Stone JA, Jayewardene AL, Chi J, Aweeka FT.
    HIV Med; 2006 Mar; 7(2):122-8. PubMed ID: 16420257
    [Abstract] [Full Text] [Related]

  • 6. Ex vivo protein binding of clindamycin in sera with normal and elevated alpha 1-acid glycoprotein concentrations.
    Kays MB, White RL, Gatti G, Gambertoglio JG.
    Pharmacotherapy; 1992 Mar; 12(1):50-5. PubMed ID: 1549539
    [Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics and pharmacodynamics of saquinavir in pediatric patients with human immunodeficiency virus infection.
    Grub S, Delora P, Lüdin E, Duff F, Fletcher CV, Brundage RC, Kline MW, Calles NR, Schwarzwald H, Jorga K.
    Clin Pharmacol Ther; 2002 Mar; 71(3):122-30. PubMed ID: 11907486
    [Abstract] [Full Text] [Related]

  • 8. Differential protein binding of indinavir and saquinavir in matched maternal and umbilical cord plasma.
    Sudhakaran S, Rayner CR, Li J, Kong DC, Gude NM, Nation RL.
    Br J Clin Pharmacol; 2007 Mar; 63(3):315-21. PubMed ID: 16981898
    [Abstract] [Full Text] [Related]

  • 9. Enantioselective plasma protein binding of bimoclomol.
    Visy J, Fitos I, Mády G, Urge L, Krajcsi P, Simonyi M.
    Chirality; 2002 Aug; 14(8):638-42. PubMed ID: 12125033
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Characterization of propofol binding to plasma proteins and possible interactions].
    Garrido MJ, Jiménez RM, Rodríguez-Sasiaín JM, Aguirre C, Aguilera L, Calvo R.
    Rev Esp Anestesiol Reanim; 1994 Aug; 41(6):308-12. PubMed ID: 7838996
    [Abstract] [Full Text] [Related]

  • 14. Altered disposition and antidepressant activity of imipramine in transgenic mice with elevated alpha-1-acid glycoprotein.
    Yoo SD, Holladay JW, Fincher TK, Baumann H, Dewey MJ.
    J Pharmacol Exp Ther; 1996 Mar; 276(3):918-22. PubMed ID: 8786570
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Binding of fosphenytoin, phosphate ester pro drug of phenytoin, to human serum proteins and competitive binding with carbamazepine, diazepam, phenobarbital, phenylbutazone, phenytoin, valproic acid or warfarin.
    Lai CM, Moore P, Quon CY.
    Res Commun Mol Pathol Pharmacol; 1995 Apr; 88(1):51-62. PubMed ID: 7620838
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of altered serum protein binding on propranolol distribution into milk in the lactating rabbit.
    Fleishaker JC, McNamara PJ.
    J Pharmacol Exp Ther; 1988 Mar; 244(3):925-8. PubMed ID: 3252038
    [Abstract] [Full Text] [Related]

  • 19. Phencyclidine blood protein binding: influence of protein, pH and species.
    Owens SM, Mayersohn M, Woodworth JR.
    J Pharmacol Exp Ther; 1983 Sep; 226(3):656-60. PubMed ID: 6887006
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.